Leiyunshang
Founded in 1734, Lei Yunshang Pharmaceutical Group has a rich heritage in traditional Chinese medicine. Its founder, Lei Da Sheng (courtesy name Yun Shang, 1696-1779), was a distinguished physician during the Qing dynasty. For nearly 300 years, Lei Yunshang has upheld its founding principles of selecting authentic medicinal ingredients and meticulously crafting premium treatments. Dedicated to both heritage preservation and innovation, the company continues to delve into the essence of traditional Chinese medicine, advancing its practices for modern needs. Headquartered in Suzhou, China, Lei Yunshang is one of the country's four major traditional medicine houses and a recognized national heritage brand. Building on a foundation rooted in traditional Chinese medicine, Lei Yunshang Group preserves cultural heritage while integrating modern technology. The organization is evolving into a science-driven and innovative organization, with capabilities spanning R&D, manufacturing, sales, pharmacy chains, wellness centers, clinics, and herb cultivation facilities. We specialize in cardiovascular, respiratory, urology, oncology, orthopedics, gastroenterology, and metabolic health. Our portfolio features a range of acclaimed traditional Chinese medicines, including Liushen Pills for throat care, Suhexiang Pills, and Jianyanling Capsules. Additionally, we offer specialized formulations such as Compound Congrong Yizhi Capsules, Bufei Huoxue Capsules, the Nao’an series, Qianggu Capsules, Qingke Pingchuan Granules, Shenshuai Ning Capsules, Lingbao Heart-Protecting Pills, and the Yadanzi Oil series. These products reflect our commitment to combining heritage with innovation to enhance patient care. Quality is at the heart of our commitment. We have established nearly a hundred herbal medicine cultivation bases, adhering to strict management standards to ensure quality control from the source. We rigorously manage the entire production process to guarantee product safety and efficacy. Additionally, we have implemented a comprehensive traceability system across the supply chain, enabling full transparency of product and raw material origins, traceability of destinations, verifiable quality, and accountable responsibility.
We are dedicated to the exploration and advancement of traditional Chinese medicine, with a strong belief in the transformative potential of modern botanical medicine for global health. As a vital component of Chinese medicine, botanical drugs offer distinct advantages in terms of transparency of ingredients, controlled quality, and reliable efficacy. This approach is a key strategic focus for expanding Lei Yunshang’s traditional Chinese medicine products and heritage internationally. Through internal R&D and strategic partnership, we continually enrich our pipeline of modern botanical medicines, uncovering and nurturing innovative projects in this field.
We have initiated several research projects to unlock the potential of traditional Chinese medicine for new indications. Over the past three years, we obtained clinical trial approvals for Liushen Capsules for COVID-19, Bufei Huoxue Capsules for COPD, and Shenshuai Ning Capsules for hyperphosphatemia, creating new opportunities in innovative healthcare solutions.
To obtain high-quality clinical evidence, we meticulously design and conduct multi-center, large-sample clinical studies across top-tier hospitals nationwide. These studies, led by leading hospitals in China, use objective and scientific research methods to demonstrate the clinical advantages and safety of our products, providing valuable support for informed clinical decisions.